Aplastic Anemia

• FDA label_change · 2020-07-23
  FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approves a supplemental application for JADENU (deferasirox) from Novartis, updating the product labeling.

• FDA label_change · 2016-10-12
  FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for PROMACTA (eltrombopag olamine) to update its labeling; this action may include changes to indica…